PHAT
Price
$10.54
Change
-$0.15 (-1.40%)
Updated
May 17, 6:59 PM EST
82 days until earnings call
ZNTL
Price
$12.07
Change
+$0.11 (+0.92%)
Updated
May 17, 6:59 PM EST
81 days until earnings call
Ad is loading...

PHAT vs ZNTL

Header iconPHAT vs ZNTL Comparison
Open Charts PHAT vs ZNTLBanner chart's image
Phathom Pharmaceuticals
Price$10.54
Change-$0.15 (-1.40%)
Volume$349.69K
CapitalizationN/A
Zentalis Pharmaceuticals
Price$12.07
Change+$0.11 (+0.92%)
Volume$282.63K
CapitalizationN/A
View a ticker or compare two or three
PHAT vs ZNTL Comparison Chart

Loading...

PHATDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ZNTLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
PHAT vs. ZNTL commentary
May 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHAT is a Hold and ZNTL is a StrongSell.

COMPARISON
Comparison
May 18, 2024
Stock price -- (PHAT: $10.54 vs. ZNTL: $12.07)
Brand notoriety: PHAT and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHAT: 75% vs. ZNTL: 71%
Market capitalization -- PHAT: $616.96M vs. ZNTL: $857.13M
PHAT [@Biotechnology] is valued at $616.96M. ZNTL’s [@Biotechnology] market capitalization is $857.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $593.52B to $0. The average market capitalization across the [@Biotechnology] industry is $2.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHAT’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • PHAT’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, ZNTL is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHAT’s TA Score shows that 6 TA indicator(s) are bullish while ZNTL’s TA Score has 4 bullish TA indicator(s).

  • PHAT’s TA Score: 6 bullish, 3 bearish.
  • ZNTL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PHAT is a better buy in the short-term than ZNTL.

Price Growth

PHAT (@Biotechnology) experienced а +10.66% price change this week, while ZNTL (@Biotechnology) price change was -3.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

PHAT is expected to report earnings on Aug 08, 2024.

ZNTL is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for PHAT with price predictions.
OPEN
A.I.dvisor published
a Summary for ZNTL with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ZNTL($857M) has a higher market cap than PHAT($617M). PHAT YTD gains are higher at: 15.444 vs. ZNTL (-20.330).
PHATZNTLPHAT / ZNTL
Capitalization617M857M72%
EBITDAN/AN/A-
Gain YTD15.444-20.330-76%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
PHATZNTL
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
PHATDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ZNTLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHLSX29.900.15
+0.50%
Diamond Hill Long-Short I
PROVX19.120.05
+0.26%
Provident Trust Strategy
MSVVX12.740.03
+0.24%
Mesirow Small Company Investor
SHAPX34.550.06
+0.17%
ClearBridge Appreciation A
HSMCX8.46-0.02
-0.24%
Hartford Small Company C

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with VERA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then VERA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
-1.40%
VERA - PHAT
43%
Loosely correlated
-1.31%
OCGN - PHAT
37%
Loosely correlated
-3.54%
ATNM - PHAT
37%
Loosely correlated
-0.51%
ATRA - PHAT
36%
Loosely correlated
+1.06%
AKRO - PHAT
32%
Poorly correlated
-3.91%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with MDGL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
+0.92%
MDGL - ZNTL
51%
Loosely correlated
+1.33%
CRSP - ZNTL
44%
Loosely correlated
+0.99%
ORMP - ZNTL
43%
Loosely correlated
-1.29%
NAUT - ZNTL
43%
Loosely correlated
+1.03%
AURA - ZNTL
42%
Loosely correlated
+0.97%
More